SAN FRANCISCO, CA—Attendees of Heart Rhythm 2022 heard results from numerous studies investigating the impact of conduction-system pacing, which includes both His-bundle and left bundle branch (LBB) ...
Late-breaking data from Abbott's groundbreaking first-in-human study demonstrated successful implantation of the company's AVEIR Conduction System Pacing (CSP) leadless pacemaker Enrollment has also ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Left bundle ...
LAKE OSWEGO, Ore., Dec. 12, 2022 /PRNewswire/ -- BIOTRONIK, a global leader in the treatment of cardiac and vascular disease is pleased to announce the first patient enrollment in BIO-CONDUCT, an FDA ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW ORLEANS -- ...
In the largest multicenter study to date on left bundle-branch area pacing (LBBAP), the technique was shown to be feasible as a primary pacing technique for treating bradyarrhythmias and heart failure ...
Conduction Pacing Momentum within Abbott ' s Cardiac Rhythm Management Portfolio To maximize potential benefits to patients, Abbott is developing two unique approaches to conduction system pacing, ...
Late-breaking data from Abbott's groundbreaking first-in-human study demonstrated successful implantation of the company's AVEIR Conduction System Pacing (CSP) leadless pacemaker Enrollment has also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback